Alpine Immune Sciences, Inc(NASDAQ:ALPN) 
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline include ALPN-101, an inducible T cell costimula...
Website: http://www.alpineimmunesciences.com
Founded: 2007
Full Time Employees: 53
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-12-01
P
O 15.51
H 15.96
L 15.17
C 15.63
V 760,618
10EMA 15.63
20EMA 15.63
60EMA 15.63
120EMA 15.63
250EMA 15.63